As nouns the difference between analogue and mitobronitol

is that analogue is (british|canadian) while mitobronitol is a brominated analogue of mannitol, used as an anticancer drug.

As an adjective analogue

is (british|canadian).

As nouns the difference between mannitol and mitobronitol

is that mannitol is (organic compound) a polyhydroxy alcohol, an isomer of sorbitol, used as an artificial sweetener while mitobronitol is a brominated analogue of mannitol, used as an anticancer drug.

As an adjective anticancer

is that is used to treat cancer.

As a noun mitobronitol is

a brominated analogue of mannitol, used as an anticancer drug.

As nouns the difference between drug and mitobronitol

is that drug is (pharmacology) a substance used to treat an illness, relieve a symptom, or modify a chemical process in the body for a specific purpose or drug can be (obsolete) a drudge while mitobronitol is a brominated analogue of mannitol, used as an anticancer drug.

As a verb drug

is to administer intoxicating drugs to, generally without the recipient's knowledge or consent or drug can be (drag).

As nouns the difference between maturation and anagrelide

is that maturation is the process of becoming mature while anagrelide is a drug that inhibits the maturation of platelets from megakaryocytes, used in the treatment of thrombocytosis and leukaemia.

As nouns the difference between platelet and anagrelide

is that platelet is (hematology|cytology) a small colorless disk-shaped particle found in the blood of mammals, which plays an important role in the formation of blood clots while anagrelide is a drug that inhibits the maturation of platelets from megakaryocytes, used in the treatment of thrombocytosis and leukaemia.

As nouns the difference between megakaryocyte and anagrelide

is that megakaryocyte is (anatomy) a large cell, found in bone marrow, responsible for the production of platelets while anagrelide is a drug that inhibits the maturation of platelets from megakaryocytes, used in the treatment of thrombocytosis and leukaemia.

As nouns the difference between thrombocytosis and anagrelide

is that thrombocytosis is the condition of having an abnormally high number of thrombocytes (platelets) in the bloodstream; can give a predisposition to thrombosis while anagrelide is a drug that inhibits the maturation of platelets from megakaryocytes, used in the treatment of thrombocytosis and leukaemia.

As nouns the difference between leukaemia and anagrelide

is that leukaemia is (uk) while anagrelide is a drug that inhibits the maturation of platelets from megakaryocytes, used in the treatment of thrombocytosis and leukaemia.

As nouns the difference between chemotherapy and talaporfin

is that chemotherapy is (medicine) any chemical treatment intended to be therapeutic with respect to a disease state while talaporfin is a photosensitizer used in chemotherapy.